デフォルト表紙
市場調査レポート
商品コード
1439665

医療用外骨格の世界市場:洞察、競合情勢、市場予測:2030年

Medical Exoskeleton - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
医療用外骨格の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用外骨格の市場規模は、2023年に2億9,558万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に18.23%のCAGRで拡大し、2030年には8億730万米ドルに達すると予測されています。医療用外骨格の需要は、主に神経障害の有病率の上昇、脊髄損傷の有病率の上昇、脳損傷の増加、医療用外骨格に関連する製品開発における技術進歩によって後押しされており、予測期間中の医療用外骨格市場の全体的な成長に寄与しています。

医療用外骨格市場は、様々な要因により製品需要が増加しています。重要な要因の1つは、神経障害の有病率の上昇です。これは、世界保健機関(WHO)が提供したデータ(2023年)から明らかであり、世界中で10億人以上が何らかの障害を抱えて生活しています。上記の情報源に加え、インドのNational Health Portal(2023)は、2022年には世界中で1,700万人以上の人々が脳性麻痺と共存していることを挙げています。さらに、MS国際連盟が発表したデータによると、2020年には世界中で約280万人近くが多発性硬化症に苦しんでいます。脳性まひは、筋肉の緊張や運動に障害をもたらし、痙縮や弛緩、反射障害、協調運動障害、不随意運動、姿勢不良、バランス障害などを引き起こします。これらの問題はすべて、人がどのように動き、ある場所から別の場所へ移動できるかに影響します。歩行中に膝が過度に曲がるクラウチ歩行は、脳性麻痺の子供によく見られる衰弱状態です。外骨格は、下肢の関節に適切なタイミングとスケールのトルクを加えることで、人間の運動機能を拡張する能力を提供します。さらに、医療用外骨格の使用は、重篤な神経疾患患者の歩行回復に影響を及ぼす可能性があるため、他の神経疾患においても多くの研究がその利点を報告しています。したがって、神経疾患の有病率の上昇に起因して、医療用外骨格に対する需要が増加し、それによって予測期間中の医療用外骨格市場の成長に寄与します。

当レポートでは、世界の医療用外骨格市場について調査し、市場の概要とともに、製品タイプ別、技術別、モビリティ別、年齢層別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 医療用外骨格市場レポートのイントロダクション

第2章 医療用外骨格市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 医療用外骨格市場の主な要因分析

  • 医療用外骨格市場の促進要因
  • 医療用外骨格市場の抑制要因と課題
  • 医療用外骨格市場の機会

第5章 医療用外骨格市場におけるポーターのファイブフォース分析

第6章 医療用外骨格市場に対するCOVID-19の影響分析

第7章 医療用外骨格市場の概要

  • 製品タイプ別
  • 技術別
  • モビリティ別
  • 年齢層別
  • 地域別

第8章 医療用外骨格市場の世界企業シェア分析-主要3~5社

第9章 医療用外骨格市場の企業と製品のプロファイル

  • ReWalks Robotics Ltd
  • Wearable Robotics srl
  • Ekso Bionics
  • CYBERDYNE INC
  • ExoAtlet
  • Hocoma
  • MARSI BIONICS, SL
  • Ottobock
  • Gogoa
  • Gloreha IDROGENET s.r.l.
  • Fourier Intelligence
  • Shanghai Siyi Intelligent Technology Co.,Ltd
  • BAMA Teknoloji
  • BIONIK

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Medical Exoskeletons Market in Global (2021-2030)
  • Table 4: Medical Exoskeletons Market in Global by Product Type (2021-2030)
  • Table 5: Medical Exoskeletons Market in Global by Technology (2021-2030)
  • Table 6: Medical Exoskeletons Market in Global by Mobility (2021-2030)
  • Table 7: Medical Exoskeletons Market in Global by Age Group (2021-2030)
  • Table 8: Medical Exoskeletons Market in Global by End User (2021-2030)
  • Table 9: Medical Exoskeletons Market in Global by Geography (2021-2030)
  • Table 10: Medical Exoskeletons Market in North America (2021-2030)
  • Table 11: Medical Exoskeletons Market in North America by Country (2021-2030)
  • Table 12: Medical Exoskeletons Market in the US (2021-2030)
  • Table 13: Medical Exoskeletons Market in Canada (2021-2030)
  • Table 14: Medical Exoskeletons Market in Mexico (2021-2030)
  • Table 15: Medical Exoskeletons Market in Europe (2021-2030)
  • Table 16: Medical Exoskeletons Market in Europe by Country (2021-2030)
  • Table 17: Medical Exoskeletons Market in France (2021-2030)
  • Table 18: Medical Exoskeletons Market in Germany (2021-2030)
  • Table 19: Medical Exoskeletons Market in the United Kingdom (2021-2030)
  • Table 20: Medical Exoskeletons Market in Italy (2021-2030)
  • Table 21: Medical Exoskeletons Market in Spain (2021-2030)
  • Table 22: Medical Exoskeletons Market in Russia (2021-2030)
  • Table 23: Medical Exoskeletons Market in Rest of Europe (2021-2030)
  • Table 24: Medical Exoskeletons Market in APAC (2021-2030)
  • Table 25: Medical Exoskeletons Market in APAC by Country (2021-2030)
  • Table 26: Medical Exoskeletons Market in China (2021-2030)
  • Table 27: Medical Exoskeletons Market in Japan (2021-2030)
  • Table 28: Medical Exoskeletons Market in India (2021-2030)
  • Table 29: Medical Exoskeletons Market in Australia (2021-2030)
  • Table 30: Medical Exoskeletons Market in South Korea (2021-2030)
  • Table 31: Medical Exoskeletons Market in Rest of APAC (2021-2030)
  • Table 32: Medical Exoskeletons Market in Rest of World (2021-2030)
  • Table 33: Medical Exoskeletons Market in RoW by Region (2021-2030)
  • Table 34: Medical Exoskeletons Market in Middle East (2021-2030)
  • Table 35: Medical Exoskeletons Market in Africa (2021-2030)
  • Table 36: Medical Exoskeletons Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Medical Exoskeletons Market in Global (2021-2030)
  • Figure 4: Medical Exoskeletons Market in Global by Product Type (2021-2030)
  • Figure 5: Medical Exoskeletons Market in Global by Technology (2021-2030)
  • Figure 6: Medical Exoskeletons Market in Global by Mobility (2021-2030)
  • Figure 7: Medical Exoskeletons Market in Global by Age Group (2021-2030)
  • Figure 8: Medical Exoskeletons Market in Global by End User (2021-2030)
  • Figure 9: Medical Exoskeletons Market in Global by Geography (2021-2030)
  • Figure 10: Medical Exoskeletons Market in North America (2021-2030)
  • Figure 11: Medical Exoskeletons Market in North America by Country (2021-2030)
  • Figure 12: Medical Exoskeletons Market in the US (2021-2030)
  • Figure 13: Medical Exoskeletons Market in Canada (2021-2030)
  • Figure 14: Medical Exoskeletons Market in Mexico (2021-2030)
  • Figure 15: Medical Exoskeletons Market in Europe (2021-2030)
  • Figure 16: Medical Exoskeletons Market in Europe by Country (2021-2030)
  • Figure 17: Medical Exoskeletons Market in France (2021-2030)
  • Figure 18: Medical Exoskeletons Market in Germany (2021-2030)
  • Figure 19: Medical Exoskeletons Market in the United Kingdom (2021-2030)
  • Figure 20: Medical Exoskeletons Market in Italy (2021-2030)
  • Figure 21: Medical Exoskeletons Market in Spain (2021-2030)
  • Figure 22: Medical Exoskeletons Market in Russia (2021-2030)
  • Figure 23: Medical Exoskeletons Market in Rest of Europe (2021-2030)
  • Figure 24: Medical Exoskeletons Market in APAC (2021-2030)
  • Figure 25: Medical Exoskeletons Market in APAC by Country (2021-2030)
  • Figure 26: Medical Exoskeletons Market in China (2021-2030)
  • Figure 27: Medical Exoskeletons Market in Japan (2021-2030)
  • Figure 28: Medical Exoskeletons Market in India (2021-2030)
  • Figure 29: Medical Exoskeletons Market in Australia (2021-2030)
  • Figure 30: Medical Exoskeletons Market in South Korea (2021-2030)
  • Figure 31: Medical Exoskeletons Market in Rest of APAC (2021-2030)
  • Figure 32: Medical Exoskeletons Market in Rest of World (2021-2030)
  • Figure 33: Medical Exoskeletons Market in RoW by Region (2021-2030)
  • Figure 34: Medical Exoskeletons Market in Middle East (2021-2030)
  • Figure 35: Medical Exoskeletons Market in Africa (2021-2030)
  • Figure 36: Medical Exoskeletons Market in South America (2021-2030)
目次
Product Code: DIMDCL0505

Medical Exoskeletons Market By Product Type (Upper Extremity And Lower Extremity), By Technology (Passive And Powered), By Mobility (Fixed/Stationary And Mobile), By Age Group (Adults And Pediatric), And By End User (Hospitals, Rehabilitation Centers, And Others), and by geography is estimated to register appreciable CAGR forecast till 2030 owing to the growing prevalence of neuroogical disorders and the rising prevalence of spinal cord injury

Global medical exoskeletons market was valued at USD 295.58 million in 2023, growing at a CAGR of 18.23% during the forecast period from 2024 to 2030 to reach USD 807.30 million by 2030. The demand for medical exoskeletons is primarily being boosted by increasing prevalence of neurological disorders, rising prevalence of spinal cord injury, increasing number of brain injuries and technological advancements in product development pertaining to medical exoskeletons contributing in the overall growth of the medical exoskeletons market during the forecast period.

Medical Exoskeletons Market Dynamics:

The medical exoskeletons market is experiencing increasing product demand due to a variety of factors. One of the important factors is the growing prevalence of neurological disorders. This is evident from the data provided by the World Health Organization (2023), over 1 billion people live with some form of disability across the globe. In addition to the above-mentioned source, the National Health Portal of India (2023) cited that in 2022, more than 17 million people across the globe were living with cerebral palsy. Furthermore, as per the data presented by the MS International Federation, in 2020, near about 2.8 million people across the globe were suffering from multiple sclerosis. Indications such as cerebral palsy causes impaired muscle tone and movement, leading to spastic or flaccid muscles, impaired reflexes, poor coordination, involuntary movements, poor posture, and impaired balance. All of these issues impact how a person moves and is able to get from one place to another. Crouch gait, the excessive bending of the knees while walking, is a common and debilitating condition in children with cerebral palsy. Exoskeletons offer the ability to augment human locomotion by applying appropriately timed and scaled torques to lower-extremity joint. Furthermore, many studies have reported benefits of employing medical exoskeletons is other neurological diseases as the use of a robotic exoskeleton can influence walking recovery in patients with a serious neurological disease. Therefore, owing to the rising prevalence of neurological disorders there will be a rise in the demand for medical exoskeletons, thereby contributing in the growth of the medical exoskeletons market during the forecast period.

Moreover, another key factor responsible for driving the demand for medical exoskeletons is the increasing prevalence of spinal cord injury. According to the National Spinal Cord Injury Statistical Center 2022, in the year 2020 the estimated number of people suffering from spinal cord injury were approximately 296,000 patients, with a range from 252,000 to 373,000 patients.

Report Metrics

Details

Study Period

2021 to 2030

Base Year

2022

Forecast Period

2024 to 2030

CAGR

18.23%

Market Size

USD 807.30 million by 2030

Key Companies

ReWalks Robotics Ltd, Wearable Robotics srl, Ekso Bionics, CYBERDYNE INC, ExoAtlet, Hocoma, MARSI BIONICS, SL, Ottobock, Gogoa, Gloreha IDROGENET s.r.l., Fourier Intelligence, Shanghai Siyi Intelligent Technology Co.,Ltd, BAMA Teknoloji, and others

Furthermore, the rising number of brain injuries is also a rising factor for driving the medical exoskeleton market during the forecasting period. As per the Centers for Disease Control and Prevention 2022, in the year 2020, approximately 61,000 TBI-related deaths had occurred in the United States in the year 2019, which accounts to about 166 TBI-related deaths every day.

However, several technology-related limitations and the higher cost associated with the devices may restrict the medical exoskeletons market growth.

The medical exoskeletons market has experienced a period of temporary recession as lockdown restrictions have been enforced as a necessary step to curb the spread of COVID-19 infections. One of the major impacts of lockdowns were observed in the disruption of production process and supply chains across the globe. Along with this, the significant decrease in the medical procedures due to prioritizing of COVID-19 infection-associated patient load, there was a striking decrease in the product demand because of that. However, the medical exoskeletons market is in the recovery stage, with numerous COVID-19 vaccines being approved and administered worldwide, and activities have begun in various areas such as medical services thereby presenting a positive growth environment for the medical exoskeletons market.

Medical Exoskeletons Market Segment Analysis:

Medical Exoskeletons Market By Product Type (Upper Extremity and Lower Extremity), By Technology (Passive and Powered), By Mobility (Fixed/Stationary and Mobile), By Age Group (Adults and Pediatric), and By End User (Hospitals, Rehabilitation Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the medical exoskeletons market, the lower extremity devices category expected to amass a significant share in the market revenue during the forecast period. This can be ascribed to their advantages such as the increase in neurological injuries such as cerebral paralysis, stroke, infectious diseases (e.g. polio), and spinal cord injury may result in significant muscle weakness and impaired motor control which severely impact the gait and motion abilities of individuals.

Another key aspect contributing in the growing demand for lower extremity medical exoskeletons is the orthopedic rehabilitation training which generally involves performing specific movements to provoke motor plasticity and ultimately improve motor recovery. It is crucial for patients to improve their musculoskeletal strength and motor control and to minimize functional deficits. An exoskeleton allows people with mobility disorders to regain the ability to stand and to walk over the ground, upstairs, and downstairs. Compared to traditional physical therapy, exoskeleton assistive rehabilitation has the advantages of reducing the work of therapists, allowing intensive and repetitive training, and it is more convenient to use for quantitatively assessing the recovery level by measuring force and movement patterns. Considering the advantages associated with these systems, there has been a growing acceptance among end users which has resulted in more products reaching the market.

For instance, in May 2019, ReWalk Robotics received the CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device.

North America is expected to dominate the overall Medical Exoskeletons Market:

Among all the regions, North America is estimated to account for the largest share in the medical exoskeletons market. Owing to significance of key growth factors such as rising prevalence of geriatric population, increasing prevalence of strokes and traumatic brain injuries, growing prevalence of neurological disorders coupled with increasing focus of the government in terms of providing access to healthcare services catering to such indications also helped the market growth in this region.

One of the major factors responsible for driving the growth of medical exoskeletons in the North American region is the rising prevalence of spinal cord injury. For instance, according to the National Spinal Cord Injury Association (2023), as many as 450,000 people in the United States were living with a spinal cord injury (SCI) in 2022. In another dataset presented by the Centers for Disease Control and Prevention, in 2019, 166 people lost their lives to a traumatic brain injury each day in 2019. The CDC (2023) further mentions that about 1 in 345 children (3 per 1,000 8-year-old children) in the United States have been identified with cerebral palsy.

All these indications affect the nervous system in varying degrees with different etiologies involved and ultimately affect a person's motor control. Therefore, the presence of large patient population suffering from neurological indications point towards the growing need for these devices in the country. This further acts as a motivating factor for manufacturers operating in the domain in gaining market access on a country level as the United States also has a reputation of availability of the best healthcare facilities in the world. For instance, in November 2022, the US Food and Drug Administration awarded the breakthrough device designation to ReWalk Robotics, Ltd's ReWalk ReBoot Soft Exo-Suit. The active involvement of the regulatory body in identifying and approving such devices to expedite the product approval process also proves beneficial to both the manufacturers and end users.

Medical Exoskeletons Market Key Players:

Some of the key market players operating in the medical exoskeletons market includes ReWalks Robotics Ltd, Wearable Robotics srl, Ekso Bionics, CYBERDYNE INC, ExoAtlet, Hocoma, MARSI BIONICS, SL, Ottobock, Gogoa, Gloreha IDROGENET s.r.l., Fourier Intelligence, Shanghai Siyi Intelligent Technology Co.,Ltd, BAMA Teknoloji, BIONIK and others.

Recent Developmental Activities In Medical Exoskeletons Market:

On June 25, 2020, Ekso Bionics had received Food and Drug Administration Clearance to market the EksoNR(TM) Robotic Exoskeleton for use with acquired brain injury patients.

On January 23, 2018, Cyberdyne had received FDA approval to begin offering the HAL (Hybrid Assistive Limb) lower-body exoskeleton to users in the United States through licensed medical facilities.

On November 01, 2018, Gogoa Mobility Robots had won the CE Mark for Hank exoskeleton.

On May 29, 2019, ReWalk Robotics had received the CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device.

Key Takeaways from the Medical Exoskeletons Market Report Study

Market size analysis for current medical exoskeletons market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the medical exoskeletons market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Medical Exoskeletons Market.

Various opportunities available for the other competitor in the Medical Exoskeletons Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current medical exoskeletons market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for medical exoskeletons market growth in the coming future?

Target Audience who can be benefited from this Medical Exoskeletons Market Report Study

Medical Exoskeletons products providers

Research organizations and consulting companies

Medical Exoskeletons -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in medical exoskeletons

Various End-users who want to know more about the Medical Exoskeletons market and latest technological developments in the Medical Exoskeletons market.

Frequently Asked Questions for Medical Exoskeletons Market:

1. What are Medical Exoskeletons?

Medical exoskeletons are medical electrical equipment which is used to provide mobility to physically disabled, injured or weak persons, who are unable to walk due to a variety of medical reasons such as SCI, neurological disorders, major trauma like stroke, cerebral palsy and so on.

2. What is the market for Global Medical Exoskeletons?

Global medical exoskeletons market was valued at USD 295.58 million in 2023, growing at a CAGR of 18.23% during the forecast period from 2024 to 2030 to reach USD 807.30 million by 2030.

3. What are the drivers for Global Medical Exoskeletons Market?

The demand for medical exoskeletons is primarily being boosted by rising prevalence of neurological disorders, growing prevalence of spinal cord injury, increasing number of brain injuries and technological advancements in the product development, thereby contributing in the overall growth of the medical exoskeletons market during the forecast period.

4. Who are the key players operating in Global Medical Exoskeletons Market?

Some of the key market players operating in the medical exoskeletons market includes ReWalks Robotics Ltd, Wearable Robotics srl, Ekso Bionics, CYBERDYNE INC, ExoAtlet, Hocoma, MARSI BIONICS, SL, Ottobock, Gogoa, Gloreha IDROGENET s.r.l., Fourier Intelligence, Shanghai Siyi Intelligent Technology Co.,Ltd, BAMA Teknoloji, BIONIK and others.

5. Which region has the highest share in Medical Exoskeletons market?

North America is expected to dominate the overall Medical Exoskeletons market during the forecast period, 2024 to 2030. Owing to significance of key growth factors such as rising prevalence of geriatric population, growing prevalence of strokes and traumatic brain injuries, rising prevalence of neurological disorders coupled with the rising focus of the government in terms of providing access to healthcare solutions catering to such indications, the North America medical exoskeletons market is expected to witness positive growth. Furthermore, higher traumatic brain injuries, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.

Table of Contents

1.Medical Exoskeletons Market Report Introduction

2.Medical Exoskeletons Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Medical Exoskeletons Market Key Factors Analysis

  • 4.1. Medical Exoskeletons Market Drivers
    • 4.1.1. Growing Prevalence of Neurological Disorders
    • 4.1.2. Increasing Prevalence of Spinal Cord Injury
    • 4.1.3. Rising Number of Brain Injuries
    • 4.1.4. Technological Advancements in Product Development
  • 4.2. Medical Exoskeletons Market Restraints and Challenges
    • 4.2.1. Technology-Related Limitations
    • 4.2.2. High Cost of Devices
  • 4.3. Medical Exoskeletons Market Opportunities
    • 4.3.1. Improving on the Product Design
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Medical Exoskeletons Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Medical Exoskeletons Market

7. Medical Exoskeletons Market Layout

  • 7.1. By Product Type
    • 7.1.1. Upper Extremity
    • 7.1.2. Lower Extremity
  • 7.2. By Technology
    • 7.2.1. Passive
    • 7.2.2. Powered
  • 7.3. By Mobility
    • 7.3.1. Fixed/Stationary
    • 7.3.2. Mobile
  • 7.4. By Age Group
    • 7.4.1. Adults
    • 7.4.2. Pediatrics
  • 7.5. By Age Group
    • 7.5.1. Adults
    • 7.5.2. Pediatrics
  • 7.6. By Geography
    • 7.6.1. North America
      • 7.6.1.1. North America Medical Exoskeletons Market, by Country
      • 7.6.1.1.1. United States
      • 7.6.1.1.2. Canada
      • 7.6.1.1.3. Mexico
    • 7.6.2. Europe
      • 7.6.2.1. Europe Medical Exoskeletons Market, by Country
      • 7.6.2.1.1. France
      • 7.6.2.1.2. Germany
      • 7.6.2.1.3. United Kingdom
      • 7.6.2.1.4. Italy
      • 7.6.2.1.5. Spain
      • 7.6.2.1.6. Russia
      • 7.6.2.1.7. Rest of Europe
    • 7.6.3. Asia-Pacific
      • 7.6.3.1. Asia-Pacific Medical Exoskeletons Market, by Country
      • 7.6.3.1.1. China
      • 7.6.3.1.2. Japan
      • 7.6.3.1.3. India
      • 7.6.3.1.4. Australia
      • 7.6.3.1.5. South Korea
      • 7.6.3.1.6. Rest of Asia Pacific
    • 7.6.4. Rest of the World (RoW)
      • 7.6.4.1. RoW Medical Exoskeletons Market, by Region

8. Medical Exoskeletons Market Global Company Share Analysis - Key 3-5 Companies

9. Medical Exoskeletons Market Company and Product Profiles

  • 9.1. ReWalks Robotics Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Wearable Robotics srl
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Ekso Bionics
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. CYBERDYNE INC
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. ExoAtlet
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Hocoma
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. MARSI BIONICS, SL
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Ottobock
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Gogoa
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Gloreha IDROGENET s.r.l.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Fourier Intelligence
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Shanghai Siyi Intelligent Technology Co.,Ltd
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. BAMA Teknoloji
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. BIONIK
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us